A Study of Radiation With Sorafenib in Advanced Cancer

NCT00610246 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: Sorafenib

Sponsor

University Health Network, Toronto